Abstract：There are many problems in the use of Bupleurum medicinal materials such as confusion in variety, unclearness in origin and quality problems, e.g., adulteration of authentic Bupleurum and mixing of non-medicinal parts. Therefore, the quality of Chinese patent medicines containing Bupleurum chinense is variable, and it is necessary to establish targeted quality control methods. Based on the quality control methods of Bupleurum and its Chinese patent medicines, combined with the example of Xiaochaihu granules, this paper discussed the quality standard improvement and supplementary test methods of Bupleurum and its Chinese patent medicines, aiming to provide reference for the quality control, quality supervision and standardized production of Chinese patent medicines containing Bupleurum and promote the improvement of its intrinsic quality.
刘潇潇, 陈馥, 林锦锋, 乔莉, 黄国凯, 李华, 马双成. 含柴胡中成药的质量控制方法探讨[J]. 中国药学杂志, 2019, 54(17): 1452-1456.
LIU Xiao-xiao, CHEN Fu, LIN Jin-feng, QIAO Li, HUANG Guo-kai, LI Hua, MA Shuang-cheng. Discussion on Quality Control Methods for Chinese Patent Medicines Containing Bupleurum. Chinese Pharmaceutical Journal, 2019, 54(17): 1452-1456.
WANG G Q. National Compilation of Chinese Herbal Medicine(全国中草药汇编)[M]. Vol 1. Beijing: People’s Medical Publishing House, 2014: 496-498.
[2]
Flora of China(中国植物志)[DB/OL]. Chinese academy of sciences,http: //frps. eflora. cn.
[3]
WANG Y Z, ZHANG Y Y. Determination of species of medical Bupleurem[J]. Chin Pharm J(中国药学杂志), 1994, 29(1):16-18.
[4]
Ch. P(2015) VolⅠ(中国药典2015年版.一部)[S]. 2015: 280.
[5]
WANG Y. Comparative study on the quality of B. marginatum Wall. ex DC. and Bupleurem chinense DC [D]. Chengdu: Chengdu University of Traditional Chinese Medicine, 2014.
[6]
GUO J Q, YANG Y J, FANG W,et al. Saikosaponins content in Bupleurum marginatum var. stenophyllum and cultivated B. chinese and B. marginatum[J]. Mod Chin Med(中国现代中药), 2018, 20(1):34-38.
[7]
WEI X M. Study on chemical composition and quality control of Bupleurum bicaule Helm [D]. Beijing: Beijing University of Chinese Medicine, 2018.
[8]
YAN H, DONG Y J, CHENG X L,et al. Identification of Bupleurum scorzonerifolium and its adulterants[J]. Chin Pharm J(中国药学杂志), 2015, 50(2): 109-114.
[9]
ZHANG P, LI M H, SHI Y, et al. Discussion on quality status and related problems of Chinese medicinal materials and decoction pieces from 2013 to 2016 in China[J]. Chin Pharm Aff(中国药事), 2018, 32(4): 438-444.
[10]
LIU H P, XIE P S, TIAN R T. HPTLC Chromatographic fingerprint analysis of Bupleurum spp.[J]. Tradit Chin Drug Res Clin Pharm(中药新药与临床药理), 2008, 19 (1): 38-42.
[11]
LU C N, YUAN Z G, ZHANG X L,et al. Saikosaponin a and its epimersaikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-κB signaling pathway[J]. Int Immunopharmacol, 2012, 14:121-125.
[12]
LIN L T, CHUNG C Y, HU W C,et al. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry[J]. J Hepatol, 2015, 62:542-546.
[13]
MA H, YOKOYAMA S, SAIKI I,et al. Chemosensitizing effect of saikosaponin B on B16F10 melanoma cells[J]. Nutr Cancer, 2017, 69(3): 506-509.
[14]
LI J, JIANG H, ZHANG Y P,et al. Differences study of dissolving behavior and structure transformation of saikosaponin a and d in the decoction of Radix Bupleuri[J]. Chin Pharm J(中国药学杂志), 2014, 49(19): 1692-1696.
[15]
LIU Y M, ZHOU A, YU N J, et al. Simultaneous determination of five saponins in Bupleuri Radix by HPLC-DAD dual wavelength method[J]. China J Pharm Mater Med (中国中药杂志), 2018, 43(2): 363-368.
[16]
LI X Q. Study on the method of Quality assessment and Pharmacokinetics of Radix Bupleuri[D]. Shenyang: Shenyang Pharmaceutical University, 2006.
[17]
HUANG W, LV Z, SUN R. Research development on chemincal compositions in Bupleurum Chinense related with efficacy and toxicity[J]. Chin J Pharmacov (中国药物警戒), 2013, 10 (9): 545-548.
[18]
LIN H X, WANG S L, WANG Y, et al. Determination of flavonoid of Bupleurum marginatum by HPLC[J]. Chin J Exp Tradit Med Form (中国实验方剂学杂志), 2012,18(15):76-79.
[19]
XIAO R, ZHANG Z F, HAN X J, et al.GC-MS Fingerprints of Radix Bupleuri from various habitats[J]. Chin Tradit Herb Drug(中草药), 2006, 37(8): 1248-1252.
[20]
SHI H X, XIE S X, XU Y L, et al.Determination of saikosaponin b1,b2 and rosmarinic acid in Jiayan Kangtai Granules by HPLC[J]. Chin Arch Tradit Chin Med (中华中医药学刊), 2018, 36(12): 2979-2982.
[21]
WANG L J, SONG Z H, CHEN X X, et al. Improved quality standard foe Weibinkang Granules by TLC coupled with RP-HPLC gradient elution[J]. Pharm J Chin PLA(解放军药学学报), 2018, 34(4): 309-312.
[22]
MO G D, YANG J, LIN L,et al. Study on quality standard of Chailing Hugan Granules[J]. J Chin Pharm(中国药房), 2018, 29(20): 2796-2799.
[23]
WANG S M, LIANG S W, WU M X, et al. Studies on the quality standard of Baixiaodan[J]. Chin Pharm J(中国药学杂志), 2001, 36(8): 554-557.
[24]
NIE L X, ZHANG Y, DAI Z, et al. The promotion of the national drug evaluation test to the improvement of Chinese medicine standards[J]. Chin Pharm (中国药业), 2013, 22(22): 2-3.
[25]
JIN S H, SU X L. Practice and prospect of drug quality surveillance in China[J]. Drug Eval(药品评价), 2010, 7(10): 24-27.
2019, Vol. 54 
